Concepedia

Jean‐Luc Specklin

JS

Statistics

Publications

9

Citations

488

H-Index

9

Active since

1992

Affiliations

Roche (Switzerland)(Current)

Idorsia (Switzerland)

Jean‐Luc Specklin is an author at Roche (Switzerland) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

1992–2024

9

Publications

9

Hydroxamic Acid Derivatives as Potent Peptide Deformylase Inhibitors and Antibacterial Agents

Christian Apfel, David W. Banner, Daniel Bur et al. · Journal of Medicinal Chemistry · 2000 · 112 citations · Full text

, , +17

Design, Synthesis, and Evaluation of 2β-Alkenyl Penam Sulfone Acids as Inhibitors of β-Lactamases

Hans Richter, Peter Angehrn, Christian Hubschwerlen et al. · Journal of Medicinal Chemistry · 1996 · 76 citations · Full text

, , +15

Structure-Based Design of β-Lactamase Inhibitors. 1. Synthesis and Evaluation of Bridged Monobactams

Ingrid Heinze‐Krauss, Peter Angehrn, Robert L. Charnas et al. · Journal of Medicinal Chemistry · 1998 · 75 citations · Full text

, , +15

Pyrimido[1,6-a]benzimidazoles: a new class of DNA gyrase inhibitors

Christian Hubschwerlen, Philippe Pflieger, Jean‐Luc Specklin et al. · Journal of Medicinal Chemistry · 1992 · 63 citations

, , +13

Structure–activity relationship in the oxazolidinone–quinolone hybrid series: influence of the central spacer on the antibacterial activity and the mode of action

Christian Hubschwerlen, Jean‐Luc Specklin, Daniel K. Baeschlin et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 51 citations · Full text

, , +15

1–5 of 9